Sekond

Sekond is a purpose-built technology platform that accelerates liquidity in the democratized alternative-investment market. The Company pioneered the Private Market Genome (“PM Genome”)—a continuously updated map linking every manager, fund, and underlying holding—that condenses months of detective work into decision-ready indicators. The Company recently announced its debut product—Sekond Ratings—which delivers data-driven ratings for evergreen/’40 Act private-equity, secondary, credit, infrastructure, and real-estate funds, pairing quartile-performance benchmarks with liquidity-risk measures. Headquartered in Boston, Sekond combines deep private-markets expertise with AI-driven analytics to provide investors with penetrating insights and clarity for private-market alternative investing. Request access to Sekond Ratings at www.sekond.co